BioSpace News Archive

Achilles Therapeutics (“Achilles”), a biopharmaceutical company developing personalised cancer immunotherapies, today announces the approval by the UK Medicines and Healthcare products Regulatory Agency (MHRA) of its Clinical Trial Application (CTA) to conduct a Phase I/II study using clonal neoantigen targeting T cells (cNeT) in patients with metastatic or recurrent melanoma.

The global interferons market is expected to post a CAGR of close to 2% during the period 2019-2023, according to the latest market research report by Technavio.

Ergomed plc (LSE: ERGO) (‘Ergomed’ or ‘the Company’), a company focused on providing specialised services to the pharmaceutical industry, announces that Stuart Jackson, Chief Financial Officer and Board Director has indicated that he will leave the Company in the Summer of 2019 to take up a position as Chief Financial Officer of a listed entity, returning to the energy sector.

Following a highly successful year and several drug discovery milestones using its flagship AI platform, Exscientia is pleased to welcome Andrew Douglas as the new Director of Data Engineering.

The study is designed to evaluate the safety and effectiveness of the catheter in treating intermittent atrial fibrillation (A Fib), the most common type of irregular heartbeat.

Instaflex® products are the top-selling branded joint health supplements at GNC, and new Instaflex Pain Relief Cream is the first topical addition to the line, giving consumers an important additional layer of support for living and moving comfortably.

In a new market insight survey conducted by HIMSS Media for Hyland Healthcare, industry leaders shared their insights on interoperable technology systems and the drive toward a more connected care experience

The most critical distinction that BuildMyBod Health brings to the world of healthcare price transparency is completeness and user friendliness. It provides consumers and employees of self-funded plans with its robust database of price information on medically necessary procedures typically paid out of pocket before a deductible is met or services that are considered cosmetic.

CIRCULOGENE announced that its molecular diagnostics laboratory has received College of American Pathologists accreditation based on a recent on-site inspection as part of CAP’s Accreditation Programs.

AKF celebrates three decades of funding vital kidney disease research through its elite fellowship program